ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.86 (3.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
ArriVent BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 925 | - | - | - |
| Enterprise Value | 642 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 18.69 | 13.00 | 19.60 | 20.64 |
| Current Ratio | 19.28 | 13.76 | 21.84 | 23.63 |
| Return on Equity (ROE) | -36.07% | -42.57% | -34.22% | - |
| Return on Assets (ROA) | -24.68% | -26.95% | -20.42% | - |
| Return on Capital (ROIC) | -26.05% | -28.58% | -21.38% | - |
| Buyback Yield / Dilution | -1230.98% | -67.64% | -79.57% | - |
| Total Shareholder Return | -1230.98% | -67.64% | -79.57% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.